Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 1
1992 6
1993 2
1994 2
1995 6
1996 6
1997 4
1998 5
1999 2
2000 15
2001 44
2002 44
2003 65
2004 103
2005 105
2006 167
2007 201
2008 336
2009 384
2010 538
2011 619
2012 748
2013 824
2014 901
2015 979
2016 999
2017 1097
2018 1133
2019 1158
2020 1356
2021 1596
2022 1580
2023 1568
2024 1242

Text availability

Article attribute

Article type

Publication date

Search Results

15,788 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer.
Harbeck N, Gnant M. Harbeck N, et al. Lancet. 2017 Mar 18;389(10074):1134-1150. doi: 10.1016/S0140-6736(16)31891-8. Epub 2016 Nov 17. Lancet. 2017. PMID: 27865536 Review.
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. ...Primary conventional surgery is not the optimal choice for all patients any more. In triple-negative and HER2-posit …
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially c …
Triple-negative breast cancer.
Foulkes WD, Smith IE, Reis-Filho JS. Foulkes WD, et al. N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389. N Engl J Med. 2010. PMID: 21067385 Free article. Review.
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. ...
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, a …
Breast Cancer Treatment: A Review.
Waks AG, Winer EP. Waks AG, et al. JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323. JAMA. 2019. PMID: 30667505 Review.
Triple-negative breast cancer is more likely to recur than the other 2 subtypes, with 85% 5-year breast cancer-specific survival for stage I triple-negative tumors vs 94% to 99% for hormone receptor positive and ERBB2 positive. ...Median …
Triple-negative breast cancer is more likely to recur than the other 2 subtypes, with 85% 5-year breast cance …
Treatment of breast cancer.
Maughan KL, Lutterbie MA, Ham PS. Maughan KL, et al. Am Fam Physician. 2010 Jun 1;81(11):1339-46. Am Fam Physician. 2010. PMID: 20521754 Free article. Review.
Understanding breast cancer treatment options can help family physicians care for their patients during and after cancer treatment. ...Anthracycline- and taxane-containing chemotherapeutic regimens are active against breast cancer. Stage III …
Understanding breast cancer treatment options can help family physicians care for their patients during and after cancer …
HER2-Low Breast Cancer: a New Subtype?
Corti C, Giugliano F, Nicolò E, Tarantino P, Criscitiello C, Curigliano G. Corti C, et al. Curr Treat Options Oncol. 2023 May;24(5):468-478. doi: 10.1007/s11864-023-01068-1. Epub 2023 Mar 27. Curr Treat Options Oncol. 2023. PMID: 36971965 Review.
Breast cancer (BC) guidelines subdivide the disease into three main groups, namely hormone receptor (HR)-positive HER2-negative, HER2-positive, and triple-negative BC (TNBC). ...Clinically focused categories cannot comprehensively describ …
Breast cancer (BC) guidelines subdivide the disease into three main groups, namely hormone receptor (HR)-positive HER2- …
Molecular Classification of Breast Cancer.
Roy M, Fowler AM, Ulaner GA, Mahajan A. Roy M, et al. PET Clin. 2023 Oct;18(4):441-458. doi: 10.1016/j.cpet.2023.04.002. Epub 2023 May 31. PET Clin. 2023. PMID: 37268505 Review.
Breast carcinomas classified based on traditional morphologic assessment provide useful prognostic information. ...This article describes the association between the different molecular subtypes with the histologic subtypes of breast cancer and illustrates ho …
Breast carcinomas classified based on traditional morphologic assessment provide useful prognostic information. ...This article descr …
Clinical implications of the intrinsic molecular subtypes of breast cancer.
Prat A, Pineda E, Adamo B, Galván P, Fernández A, Gaba L, Díez M, Viladot M, Arance A, Muñoz M. Prat A, et al. Breast. 2015 Nov;24 Suppl 2:S26-35. doi: 10.1016/j.breast.2015.07.008. Epub 2015 Aug 5. Breast. 2015. PMID: 26253814 Review.
Gene-expression profiling has had a considerable impact on our understanding of breast cancer biology. During the last 15 years, 5 intrinsic molecular subtypes of breast cancer (Luminal A, Luminal B, HER2-enriched, Basal-like and Claudin-low) ha …
Gene-expression profiling has had a considerable impact on our understanding of breast cancer biology. During the last 15 year …
Breast Cancer: Current Molecular Therapeutic Targets and New Players.
Nagini S. Nagini S. Anticancer Agents Med Chem. 2017;17(2):152-163. doi: 10.2174/1871520616666160502122724. Anticancer Agents Med Chem. 2017. PMID: 27137076 Review.
Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide. Breast cancer is a complex, heterogeneous disease classified into hormone-receptor-positive, human epidermal growth factor receptor …
Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide. Br …
PI3K Inhibitors in Breast Cancer Therapy.
Ellis H, Ma CX. Ellis H, et al. Curr Oncol Rep. 2019 Dec 11;21(12):110. doi: 10.1007/s11912-019-0846-7. Curr Oncol Rep. 2019. PMID: 31828441 Review.
Alpelisib in combination with fulvestrant is now available in the clinic for postmenopausal women with advanced or metastatic hormone receptor (HR)-positive, HER2-negative, PIK3CA-mutated breast cancer. In addition, promising data has been observed in …
Alpelisib in combination with fulvestrant is now available in the clinic for postmenopausal women with advanced or metastatic hormone recept …
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA. Howlader N, et al. J Natl Cancer Inst. 2014 Apr 28;106(5):dju055. doi: 10.1093/jnci/dju055. J Natl Cancer Inst. 2014. PMID: 24777111 Free PMC article.
BACKGROUND: In 2010, Surveillance, Epidemiology, and End Results (SEER) registries began collecting human epidermal growth factor 2 (HER2) receptor status for breast cancer cases. METHODS: Breast cancer subtypes defined by joint hormone receptor …
BACKGROUND: In 2010, Surveillance, Epidemiology, and End Results (SEER) registries began collecting human epidermal growth factor 2 (HER2 …
15,788 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "her2 negative breast cancer"